Kunshi Biology: Completed the registration of the first grant of 24.7 million A-share stock options.

KingTruth Biotech announced that the company has completed the initial registration of the 2025 A-share stock option incentive plan, with a registration date of November 14, 2025. The registered quantity is 24.70 million shares, granted to 226 individuals at a price of 46.67 yuan per share, sourced from a targeted issue of A-shares. Nine incentive recipients have forfeited 450,000 options. The incentive plan has a maximum validity period of 48 months, with the initial options granted in two vesting periods, each with a 50% vesting ratio. It is estimated that a total expense of 189.9525 million yuan will be amortized from 2025 to 2027, with allocations of 33.7991 million yuan, 115.0864 million yuan, and 41.067 million yuan respectively.